Centerra Gold (CG) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Produced 93,712 ounces of gold and 13.7 million pounds of copper in Q3 2024, maintaining consistent operating performance and strong free cash flow generation, with cash and equivalents rising to $604 million despite $32 million spent on Thompson Creek restart.
Advanced strategic initiatives, including Mount Milligan PEA, a new Royal Gold agreement, and U.S. molybdenum asset optimization, with Thompson Creek restart and Langeloth ramp-up progressing.
Achieved notable ESG milestones, including awards for social responsibility and Indigenous employment programs.
Increased share buybacks to $12 million and declared a quarterly dividend, maintaining a disciplined capital return approach.
Financial highlights
Q3 2024 net earnings were $28.8 million ($0.14/share); adjusted net earnings were $39 million ($0.19/share).
Q3 gold sales were 96,736 ounces at an average realized price of $2,206/oz; copper sales were 14.2 million pounds at $3.37/lb.
Consolidated all-in sustaining costs (AISC) on a byproduct basis were $1,302/oz.
Free cash flow was $37 million; cash flow from operations was $104 million.
Ended Q3 with $604 million in cash and $1 billion in total liquidity.
Outlook and guidance
On track to meet consolidated 2024 production and cost guidance: 370,000–410,000 oz gold and 55–65M lbs copper.
Mount Milligan and Öksüt production and cost guidance ranges remain unchanged, with Mount Milligan trending to the lower end of gold production guidance.
Expect lower AISC at Mount Milligan in Q4 due to higher sales and lower sustaining CapEx.
Öksüt Q4 production expected to be 15–20% of annual total, with higher AISC due to lower grades and elevated royalty costs.
2024 capital expenditures guided at $157–$195 million, with sustaining capex at $101–$127 million.
Latest events from Centerra Gold
- 2025 exceeded production and financial targets, advancing growth and delivering record returns.CG
Q4 202520 Feb 2026 - Strong balance sheet and discounted valuation support organic growth in gold, copper, and molybdenum.CG
Investor presentation20 Feb 2026 - Q2 2024 saw strong results, robust liquidity, and ongoing capital returns with steady guidance.CG
Q2 20242 Feb 2026 - Restart and ramp-up of US molybdenum assets target $472M NPV8% and 22% IRR by 2028.CG
Investor Update20 Jan 2026 - 2024 delivered robust cash flow; 2025 to focus on disciplined spending and project growth.CG
Q4 202421 Dec 2025 - All director nominees, auditor appointment, and executive compensation motions were approved.CG
AGM 202525 Nov 2025 - Q1 2025 saw strong cash flow, robust liquidity, and major project advances.CG
Q1 202524 Nov 2025 - Strong Q2 results, robust liquidity, and project advances offset by higher cost guidance.CG
Q2 202523 Nov 2025 - Q3 2025 saw strong free cash flow, project progress, and robust shareholder returns.CG
Q3 202530 Oct 2025